JP2023547062A - 改変放出ソフトゲルカプセル - Google Patents

改変放出ソフトゲルカプセル Download PDF

Info

Publication number
JP2023547062A
JP2023547062A JP2023523094A JP2023523094A JP2023547062A JP 2023547062 A JP2023547062 A JP 2023547062A JP 2023523094 A JP2023523094 A JP 2023523094A JP 2023523094 A JP2023523094 A JP 2023523094A JP 2023547062 A JP2023547062 A JP 2023547062A
Authority
JP
Japan
Prior art keywords
modified release
composition
controlled release
dependent
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023523094A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023547062A5 (https=
JPWO2022082222A5 (https=
Inventor
スクル，カルナカー
ファング，チー
Original Assignee
アール．ピー．シェーラー テクノロジーズ，エルエルシー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アール．ピー．シェーラー テクノロジーズ，エルエルシー filed Critical アール．ピー．シェーラー テクノロジーズ，エルエルシー
Publication of JP2023547062A publication Critical patent/JP2023547062A/ja
Publication of JP2023547062A5 publication Critical patent/JP2023547062A5/ja
Publication of JPWO2022082222A5 publication Critical patent/JPWO2022082222A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2023523094A 2020-10-16 2021-10-15 改変放出ソフトゲルカプセル Pending JP2023547062A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063092762P 2020-10-16 2020-10-16
US63/092,762 2020-10-16
PCT/US2021/071900 WO2022082222A1 (en) 2020-10-16 2021-10-15 Modified release softgel capsules

Publications (3)

Publication Number Publication Date
JP2023547062A true JP2023547062A (ja) 2023-11-09
JP2023547062A5 JP2023547062A5 (https=) 2024-10-22
JPWO2022082222A5 JPWO2022082222A5 (https=) 2024-10-22

Family

ID=81208677

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023523094A Pending JP2023547062A (ja) 2020-10-16 2021-10-15 改変放出ソフトゲルカプセル

Country Status (14)

Country Link
US (1) US20230390210A1 (https=)
EP (1) EP4228597A4 (https=)
JP (1) JP2023547062A (https=)
KR (1) KR20230088388A (https=)
CN (1) CN116322655A (https=)
AR (1) AR123805A1 (https=)
AU (1) AU2021362248A1 (https=)
BR (1) BR112023006154A2 (https=)
CA (1) CA3194160A1 (https=)
CO (1) CO2023005753A2 (https=)
IL (1) IL301715A (https=)
MX (1) MX2023004418A (https=)
TW (1) TW202228656A (https=)
WO (1) WO2022082222A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025135085A1 (ja) * 2023-12-22 2025-06-26 花王株式会社 カプセル剤

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120301546A1 (en) * 2011-05-26 2012-11-29 Hassan Emadeldin M Acid-resistant soft gel compositions
US20150366814A1 (en) * 2014-06-23 2015-12-24 Banner Life Sciences Llc All-natural enteric soft capsules comprising active ingredients

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
US7842307B2 (en) * 2001-08-06 2010-11-30 Purdue Pharma L.P. Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent
KR20100047349A (ko) * 2001-11-22 2010-05-07 모리시타 진탄 가부시키가이샤 비젤라틴계 캡슐 피막 조성물 및 이를 이용한 캡슐
KR100575199B1 (ko) * 2003-01-24 2006-05-02 알앤피코리아주식회사 연질 캡슐의 블루밍 방지를 위한 가소제 조성물 및 이를함유한 피막
IT1401313B1 (it) * 2010-08-05 2013-07-18 Perfetti Van Melle Spa Caramelle gelatinose con ripieno fluido e metodo di ottenimento
GB201304662D0 (en) * 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
GB201319792D0 (en) * 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
US20170119680A1 (en) * 2015-10-30 2017-05-04 R.P. Scherer Technologies, Llc Extended release film-coated capsules
US20210353574A1 (en) * 2018-10-16 2021-11-18 Bayer Healthcare Llc Softgels with solid or gel-like polymeric fill matrix
MX2022005050A (es) * 2019-10-28 2022-07-04 Scherer Technologies Llc R P Cápsulas de gelatina blanda de liberación retardada en entorno de ph más alto.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120301546A1 (en) * 2011-05-26 2012-11-29 Hassan Emadeldin M Acid-resistant soft gel compositions
US20150366814A1 (en) * 2014-06-23 2015-12-24 Banner Life Sciences Llc All-natural enteric soft capsules comprising active ingredients

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF FOOD SCIENCE AND AGRICULTURAL TECHNOLOGY, vol. 1, no. 1, JPN6025039007, 2015, pages 26 - 30, ISSN: 0005812965 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025135085A1 (ja) * 2023-12-22 2025-06-26 花王株式会社 カプセル剤
JP2025100463A (ja) * 2023-12-22 2025-07-03 花王株式会社 カプセル剤
JP7766777B2 (ja) 2023-12-22 2025-11-10 花王株式会社 カプセル剤

Also Published As

Publication number Publication date
CO2023005753A2 (es) 2023-05-29
EP4228597A4 (en) 2024-10-02
AU2021362248A1 (en) 2023-06-01
MX2023004418A (es) 2023-05-04
TW202228656A (zh) 2022-08-01
US20230390210A1 (en) 2023-12-07
CN116322655A (zh) 2023-06-23
KR20230088388A (ko) 2023-06-19
CA3194160A1 (en) 2022-04-21
AR123805A1 (es) 2023-01-11
WO2022082222A1 (en) 2022-04-21
BR112023006154A2 (pt) 2023-05-09
IL301715A (en) 2023-05-01
AU2021362248A9 (en) 2024-05-02
EP4228597A1 (en) 2023-08-23

Similar Documents

Publication Publication Date Title
JP7558204B2 (ja) 遅延放出ソフトゲルカプセル
EP4051016B1 (en) Delayed release softgel capsules in higher ph environment
JP7727623B2 (ja) 非動物性ソフトゲルカプセル製剤、その調製方法、およびその使用方法
JP2023547062A (ja) 改変放出ソフトゲルカプセル
JP2023532180A (ja) 遅延放出ソフトゲルカプセル
AU2021360905B2 (en) Controlled release fill compositions and capsules containing same
HK40095991A (zh) 调节释放软凝胶胶囊
HK40090240A (zh) 控释填料组合物和含有该组合物的胶囊
JP2009501796A (ja) 睡眠薬の放出調整
TW202428248A (zh) 軟膠囊及用於製備軟膠囊的方法
JP2025527319A (ja) コーティングされた腸溶性ソフトゲルカプセル剤
HK40129573A (zh) 软凝胶胶囊和制备软凝胶胶囊的方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241011

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20241011

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20250919

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250924

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251223

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260310